Literature DB >> 7681814

HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues.

J A McCutcheon1, K D Smith, A Valenzuela, K Aalbers, C T Lutz.   

Abstract

We examine the effect of mutations in the HLA-B*0702 alpha 1 domain on the binding of several well-characterized monoclonal antibodies. BB7.1 recognizes the alpha-helix, with a special requirement for residue 67. Combined with an established requirement for the alpha 2 alpha-helix, BB7.1 appears to span the B*0702 peptide-binding groove. Alternatively, BB7.1 epitope conformation may be altered by distant B*0702 sites. ME1 and B27M1 recognize connecting loop residues 41 and 43 and alpha 1 alpha-helical residues 67-71. Instead of contacting residue 67-71 side chains directly, however, ME1 appears to recognizes a B*0702 configuration that depends upon the proper interaction of these and other HLA residues. In addition to solvent-accessible residues 41 and 43, the B27M1 epitope depends on solvent-inaccessible residue 32 at the bottom of the peptide-binding groove. MB40.2, known to require residues 169-182 near the alpha 2-alpha 3 junction, also requires the proper combination of distant residues in the alpha 1 beta-strand and alpha-helix. The effect of mutations near the peptide-binding groove suggests that bound peptides may directly or indirectly affect HLA epitopes. These results illustrate that HLA epitope conformation is very sensitive to changes at distant HLA sites and forecast that epitope models based on sequential amino acid residues will often fail to predict HLA epitopes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681814     DOI: 10.1016/0198-8859(93)90108-d

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  A structurally based approach to determine HLA compatibility at the humoral immune level.

Authors:  Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2006-09-01       Impact factor: 2.850

Review 2.  Conformational changes in MHC class I molecules. Antibody, T-cell receptor, and NK cell recognition in an HLA-B7 model system.

Authors:  K D Smith; Z B Kurago; C T Lutz
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.

Authors:  K D Smith; D F Epperson; C T Lutz
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes.

Authors:  M Wuorela; S Jalkanen; J Kirveskari; P Laitio; K Granfors
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules.

Authors:  H G Hilton; P Parham
Journal:  Tissue Antigens       Date:  2013-04

6.  The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.

Authors:  Alberto Cauli; Jacqueline Shaw; Joanna Giles; Hiroko Hatano; Oliwia Rysnik; Sravan Payeli; Kirsty McHugh; Grazia Dessole; Giovanni Porru; Elisabetta Desogus; Sarah Fiedler; Soraya Hölper; Amanda Carette; Miguel Angel Blanco-Gelaz; Alessandra Vacca; Matteo Piga; Valentina Ibba; Pietro Garau; Giorgio La Nasa; Carlos López-Larrea; Alessandro Mathieu; Christoph Renner; Paul Bowness; Simon Kollnberger
Journal:  Rheumatology (Oxford)       Date:  2013-06-26       Impact factor: 7.580

7.  KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis.

Authors:  Isabel Wong-Baeza; Anna Ridley; Jackie Shaw; Hiroko Hatano; Oliwia Rysnik; Kirsty McHugh; Christopher Piper; Simon Brackenbridge; Ricardo Fernandes; Anthoni Chan; Paul Bowness; Simon Kollnberger
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.